Abstract:The laminin-5 gamma 2 chain (LN-5gamma2) is known to be a marker of invasion in several cancer types. Our purpose was to examine the prognostic significance of LN-5gamma2 expression in different areas of individual colorectal cancers (CRCs) by using tissue microarrays (TMAs), and to clarify the optimal areas for prognostic assessment. Using formalin-fixed paraffin-embedded tissue blocks of pT3 primary CRCs resected from 120 patients, we constructed TMA blocks of tissue core specimens taken from the submucosal invasive front, subserosal invasive front, central area, and rolled edge of each tumor. Using these four-point TMA sets, cytoplasmic LN-5gamma2 expression was immunohistochemically surveyed, and the area-specific prognostic significance of LN-5gamma2 expression was evaluated. The data revealed that 35, 30, 15 and 10% of the 120 CRCs showed high-grade LN-5gamma2 expression in the submucosal invasive front, subserosal invasive front, central area and rolled edge, respectively. Disease-specific survival curves for the groups with high- and low-grade LN-5gamma2 in the submucosal invasive front and subserosal invasive front were different significantly or of marginal difference (respective 5-year survival rates: 54 and 78% for submucosal invasive front (P=0.030) and 58 and 75% for subserosal invasive front (P=0.055)). Multivariate analysis revealed that the grades of LN-5gamma2 expression in submucosal invasive front (hazard ratio=2.0, P=0.047) and subserosal invasive front (hazard ratio=2.9, P=0.0033) were independent prognostic factors. In contrast, the grades of LN-5gamma2 expression in the central area and rolled edge did not have a significant impact on patient prognosis. Analysis using area-specific four-point TMAs clearly demonstrated that LN-5gamma2 expression in the invasive front largely influences the degree of clinical aggressiveness of CRC and its tendency to metastasize.

Expression of LN-5 in lung adenocarcinoma tissue and its relationship with EGFR mutations

Expression pattern of laminin 332α3 chain is correlated with invasion and metastasis of pancreatic ductal adenocarcinoma

The Prognostic Role of Eg5 Expression in Laryngeal Squamous Cell Carcinoma.

Expression of EPHA5 in lung adenocarcinoma is associated with lymph node metastasis and EGFR mutation

Aberrant Expression of SCARA5 in Lung Adenocarcinoma and its Clinical Significance

Lgr5-positive Cells in the Lung and Their Clinical Significance in Patients with Lung Adenocarcinoma

Elevated Expression Level of Laminin 5 May Be a Negative Predictive Factor for the Response to Gefitinib in Lung Cancer Patients

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

Extracellular matrix expression in non small cell lung cancer and its relationship with neo-adjuvant chemotherapy

Leucine‐rich repeat‐containing G protein‐coupled receptor 5 expression in lymph node metastases of colorectal cancer: Clinicopathological insights and prognostic implications

Expression and Significance of Lgr5 in Colorectal Carcinoma

The Significance of EGFR Expression in Squamous Cell Carcinoma and Adenocarcinoma of Lung

The Relationship Between Laminin Expression and Clinical Pathological Features in Esophageal Squamous Cell

Expression and significance of HMGN5 in lung cancer cell

Study on expression and significance of epidermal growth factor receptor in 70 cases with non-small cell lung cancer

Prognostic implication of laminin-5 gamma 2 chain expression in the invasive front of colorectal cancers, disclosed by area-specific four-point tissue microarrays

Overexpression of ANLN in Lung Adenocarcinoma is Associated with Metastasis.

Clinical Significance and Expression of Wnt5a in Lung Squamous Cell Carcinoma and Adencarcinoma

Clinical Significance of the Expression of Lung Resistance Protein in Non-Small Cell Lung Carcinomas

Expression and function of laminin receptor in laryngeal squamous cell carcinoma]

Lamin B1 Overexpresses in Lung Adenocarcinoma and Promotes Proliferation in Lung Cancer Cells Via AKT Pathway.